Medpace Holdings Inc. said investment funds affiliated with Cinven Capital Management (V) General Partner Ltd. will offer 4 million common shares of the company in a secondary offering.
In addition, Cinven has granted the underwriters an option to buy up to an additional 600,000 common shares.
Medpace will not receive any proceeds from the sale of the shares.
Jefferies LLC and Credit Suisse Securities (USA) LLC are acting as book runners for the offering.
